Stay updated on NUC-7738 in Advanced Solid Tumours: Clinical Trial
Sign up to get notified when there's something new on the NUC-7738 in Advanced Solid Tumours: Clinical Trial page.

Latest updates to the NUC-7738 in Advanced Solid Tumours: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.0 to v3.4.2 on the page.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now displays a 'Last Update Posted' field and the '(Estimated)' label has been removed, changing how updates are labeled but not altering substantive trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded Phase II melanoma cohort eligibility expansion for NUC-7738 + pembrolizumab: metastatic cutaneous melanoma patients with measurable disease who progressed on up to two prior lines, with at least one PD-1/PD-L1-containing regimen. The progression-in-last-12-months constraint was removed, and the record shows Revision: v3.3.4 with Last Update Posted 2026-01-12.SummaryDifference0.7%

- Check62 days agoChange DetectedFooter now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed on the page. This is a metadata update and does not affect the study information presented.SummaryDifference0.0%

- Check98 days agoChange DetectedThe government funding status notice was removed from the page. No other substantive study details were altered; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to NUC-7738 in Advanced Solid Tumours: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NUC-7738 in Advanced Solid Tumours: Clinical Trial page.